Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
about
Toxic epidermal necrolysis and Stevens-Johnson syndromeToxic epidermal necrolysisCytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsStevens-johnson syndrome associated with drugs and vaccines in children: a case-control studyFactors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysisStevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected WomenToxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case reportDoes hypernatremia impact mortality in Toxic Epidermal Necrolysis?Cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteinePhenytoin-induced Lyell's syndrome.Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trialCauses and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.Are Multimorbidities Underestimated in Scoring Systems of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Like in SCORTEN?Ruptured inflammatory aortic aneurysm with aortoenteric fistula and infected with Streptococcus pneumoniae: a review of the literatureMedicine in the elderly.Sjögren-like pluriglandular exocrine insufficiency after drug-induced toxic epidermal necrolysis.Idiosyncratic adverse reactions to antiepileptic drugs.Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome.The use of i.v. IG therapy in dermatology.Drug induced toxic epidermal necrolysis: two case reports.Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms.Toxic epidermal necrolysis with ocular involvement following vaccination for hemorrhagic fever with renal syndrome.Relationship between kinetics of lesional cytokines and secondary infection in inflammatory skin disorders: a hypothesis.Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.Life-threatening dermatologic adverse events in oncologyA case of Stevens-Johnson syndrome with gross hematuria.Toxic epidermal necrolysis. A study of the sweat glands.60-year-old man with rash.Don't live in a town where there are no doctors: toxic epidermal necrolysis initially misdiagnosed as oral thrush.Juvenile xanthogranuloma in neurofibromatosis type I.Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.Toxic epidermal necrolysis: a paradigm of critical illness.Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.Toxic epidermal necrolysis complicated by delayed mucosal healing and haemorrhagic mucositis.An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.
P2860
Q21202877-EF2A54F0-A2C3-42A9-A190-5D391BDD4704Q26745232-CCB206CF-34C9-4FDD-8E6A-BDA13DB2EF09Q28395744-C4A674FE-EE7E-47BF-83F5-9AD847011D25Q28534684-A987A2EA-6FBB-4E60-B42E-F590499F043DQ28541785-D6D5EE6C-240F-4F15-B381-31FE90280E40Q28547203-2C922F9A-119A-4684-81D9-634425B7B232Q30752612-3FE63E3E-4585-486C-9FDA-4D07EEF8B7D3Q33374316-9FFABCF0-8FFA-4E2F-A87D-7E9694EAB160Q33398324-8561754B-DDD3-4A74-ACFE-09A9582ECAC1Q33587297-FAD58352-1CC1-475D-8A01-0D528D8E63FDQ34285597-7289ECC7-9DDA-4200-9F07-6F3AE8E1D165Q35545025-864D3B2D-1F9C-4829-B3F3-21B4DEC809BEQ35982729-62A11448-EC0D-4AB7-8A10-A845CE06D7C3Q35987000-77DBFD42-4C64-40B0-BACF-62844CE6AA05Q36025252-E598E560-BB0C-4576-A8A7-23F96460D08CQ36138175-82F328C2-0987-4D1F-8EB3-4D050615138BQ36261561-278585ED-94C6-4F73-8FAF-44998B9D29B3Q36681634-40118F9A-AB56-4ED7-9D1B-20A0D7BEA62DQ36681941-6D065895-BBD0-46A8-99CA-27BA9E932DC1Q36770454-537F72F2-D981-4D61-9412-7EB2117A1A79Q36813829-C7CC2E3A-5251-40CC-B243-5CA10636CECBQ36986054-69F0720B-B0C2-4345-9B8D-64E411A1868EQ37403485-6C98288D-C285-477A-9AA3-4AE3D08A1E96Q38457053-8AA27F2E-FB81-4462-8E2A-FF0CBD0CD742Q40126460-CB313A99-B31F-43F9-B659-E878B8177D32Q40820212-78399474-799A-4820-9DD8-BA5D86808328Q41265631-B8E33175-42E2-4A2B-8C21-8DC866CCEAE3Q41494133-CADD727F-28EE-498B-A102-4299EF892AE6Q41858674-06DC85B0-05F2-47F7-8251-2054ADC13B39Q41869634-7C04AC67-F6AC-4E04-BC6D-2F11B36CD398Q42290001-84752CC9-8D88-403F-93CB-39DBA7FC7FB6Q42475110-C7242B3B-FC53-4374-8201-3559827066AAQ42540871-77A1B1BA-3847-49A5-BA89-AF0BB0149F22Q42582535-F750CB0C-701C-4571-BE8D-6CB0E8AADE34Q44253531-B5B2D062-5674-4331-B7BB-8961CD70ED8BQ44255641-528DF775-2C2C-4267-A678-302B66B08D94Q49468674-4A9D2B2A-F2C1-411E-B1C9-F4E87CBCBB61Q50063459-A1CB41F5-85D3-478A-9106-8635C681EFD5Q51666361-5C983BF7-922C-4F9D-B776-1D29DBB56DE5Q52719665-25DFBEC4-10EE-4521-B314-3FB313D36A52
P2860
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@ast
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@en
type
label
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@ast
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@en
prefLabel
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@ast
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@en
P2093
P1433
P1476
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
@en
P2093
Guillaume JC
Roujeau JC
Touraine R
Wechsler J
P304
P356
10.1001/ARCHDERM.123.9.1160
P577
1987-09-01T00:00:00Z